| Sulfatinib |
索凡替尼 |
1816307-67-1 |
| Azidoacetic acid methyl ester |
叠氮乙酸甲酯 |
1816-92-8 |
| 5-NITRO-1H-PYRAZOLE-3-CARBOXYLIC ACID METHYL ESTER |
5-硝基-1H-吡唑-3-羧酸甲酯 |
181585-93-3 |
| (3-CYANOPROPYL)DIMETHYLCHLOROSILANE |
(3-氰基丙基)二甲基氯硅烷 |
18156-15-5 |
| 1,3-Benzodioxole-5-propanoic acid, β-amino-, methyl ester, (βS)- |
1,3-Benzodioxole-5-propanoic acid, β-amino-, methyl ester, (βS)- |
181517-86-2 |
| LEM-14 |
化合物 T9006 |
1814881-70-3 |
| DT-061 |
SMAP |
1809427-19-7 |
| Apremilast Impurity 10 |
阿普斯特杂质 10 |
1809170-71-5 |
| N-((2R,3S)-2-(4-Chlorophenyl)-1-(1,4-dimethyl-2-oxo-1,2-dihydroquinolin-7-yl)-6-oxopiperidin-3 |
化合物LP99 |
1808951-93-0 |
| Gilvetmab |
Gilvetmab |
1808081-43-7 |
| EPZ031686 |
CS-2707 |
1808011-22-4 |
| Gedivumab |
Gedivumab |
1807954-17-1 |
| IACS-10759 Hydrochloride |
1807523-99-4 |
1807523-99-4 |
| ISOTHIOCYANIC ACID 4-PENTEN-1-YL ESTER |
4-戊烯基异硫氰酸酯 |
18060-79-2 |
| 2-Chloro-4'-fluorobenzophenone |
2-氯-4'-氟二苯甲酮 |
1806-23-1 |
| Hydrazinium hydroxide |
4-(5-氯-2-乙氧基-4-氟苯甲酰氨基)-3,3-二甲基丁酸 |
1805818-57-8 |
| 3-FLUORO-5-METHOXYPYRIDIN-4-AMINE |
3-氟-5-甲氧基吡啶-4-胺 |
1804379-42-7 |
| 1H-Benzimidazole-6-carboxylic acid, 7-bromo-, methyl ester |
4-溴苯并咪唑-5-甲酸甲酯 |
1803895-46-6 |
| (S)-5-fluoro-3-methylisobenzofuran-1(3H)-one |
(S)-5-氟-3-甲基异苯并呋喃-3-酮 |
1803573-19-4 |
| BAY-1436032 |
2-[[4-(三氟甲氧基)苯基]氨基]-1-[(1R,5R)-3,3,5-三甲基环己基]-1H-苯并咪唑-5-丙酸 |
1803274-65-8 |
QQ
微信
